Home > Insider Trading > Filing (0001209191-21-055483)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-02	42	$3.34	15,456	No	4	P	Direct
Common Stock	Acquisiton	2021-08-03	42	$3.17	15,498	No	4	P	Direct
Common Stock	Acquisiton	2021-08-04	42	$3.18	15,540	No	4	P	Direct
Common Stock	Acquisiton	2021-08-05	42	$3.11	15,582	No	4	P	Direct
Common Stock	Acquisiton	2021-08-06	42	$3.01	15,624	No	4	P	Direct
Common Stock	Acquisiton	2021-08-09	42	$2.93	15,666	No	4	P	Direct
Common Stock	Acquisiton	2021-08-10	42	$2.96	15,708	No	4	P	Direct
Common Stock	Acquisiton	2021-08-11	42	$2.98	15,750	No	4	P	Direct
Common Stock	Acquisiton	2021-08-13	42	$2.92	15,792	No	4	P	Direct
Common Stock	Acquisiton	2021-08-16	42	$2.92	15,834	No	4	P	Direct
Common Stock	Acquisiton	2021-08-17	42	$3.05	15,876	No	4	P	Direct
Common Stock	Acquisiton	2021-08-18	42	$2.97	15,918	No	4	P	Direct
Common Stock	Acquisiton	2021-08-19	42	$3.02	15,960	No	4	P	Direct
Common Stock	Acquisiton	2021-08-20	42	$2.96	16,002	No	4	P	Direct
Common Stock	Acquisiton	2021-08-23	42	$2.87	16,044	No	4	P	Direct
Common Stock	Acquisiton	2021-08-24	42	$2.89	16,086	No	4	P	Direct
Common Stock	Acquisiton	2021-08-25	42	$2.79	16,128	No	4	P	Direct
Common Stock	Acquisiton	2021-08-26	42	$2.82	16,170	No	4	P	Direct
Common Stock	Acquisiton	2021-08-27	42	$2.84	16,212	No	4	P	Direct
Common Stock	Acquisiton	2021-08-30	42	$2.88	16,254	No	4	P	Direct
Common Stock	Acquisiton	2021-08-31	42	$2.93	16,296	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.